SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Joyner J. David

(Last) (First) (Middle)
ONE CVS DRIVE

(Street)
WOONSOCKET RI 02895

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVS CAREMARK CORP [ CVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Sales & Account Services
3. Date of Earliest Transaction (Month/Day/Year)
09/13/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/13/2012 S (1) 20,000 D $47 1,786 D
Common Stock (restricted) 48,419 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $20.23 09/13/2012 M 20,000 03/22/2007 (2) 03/01/2015 Common Stock 20,000 $0 73,903 D
Stock Option $34.42 04/02/2008 (3) 04/02/2014 Common Stock 125,250 125,250 D
Stock Option $41.17 04/01/2009 (4) 04/01/2015 Common Stock 95,135 95,135 D
Stock Option $28.1 04/01/2010 (5) 04/01/2016 Common Stock 77,619 77,619 D
Stock Option $36.23 04/01/2011 (6) 04/01/2017 Common Stock 45,897 45,897 D
Stock Option $34.96 04/01/2012 (7) 04/01/2018 Common Stock 48,230 48,230 D
Stock Option $45.07 04/02/2013 (8) 04/02/2019 Common Stock 35,492 35,492 D
Explanation of Responses:
1. All sales were effected pursuant to a Rule 10b5-1 plan.
2. Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rs, Inc. stock option to CVS Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.
3. Option became exercisable in three equal annual installments, commencing 4/2/2008.
4. Option became exercisable in three equal annual installments, commencing 4/1/2009.
5. Option became exercisable in three equal annual installments, commencing 4/1/2010.
6. Option became exercisable in three equal annual installments, commencing 4/1/2011.
7. Option became exercisable in four equal annual installments, commencing 4/1/2012.
8. Option becomes exercisable in four equal annual installments, commencing 4/2/2013.
/s/ J. David Joyner 09/14/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.